-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/liquid-biopsy-topicrefinement.pdf
July 29, 2021 - Circulating Tumor DNA
Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon … s41586-020-2140-0
36
screening technologies, such as newer stool-based tests, CT colonography, or colon
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/liquid-biopsy-topicrefinement.pdf
July 29, 2021 - Circulating Tumor DNA
Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon … s41586-020-2140-0
36
screening technologies, such as newer stool-based tests, CT colonography, or colon
-
www.cpsi.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/liquid-biopsy-topicrefinement.pdf
July 29, 2021 - Circulating Tumor DNA
Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon … s41586-020-2140-0
36
screening technologies, such as newer stool-based tests, CT colonography, or colon
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/liquid-biopsy-topicrefinement.pdf
July 29, 2021 - Circulating Tumor DNA
Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon … s41586-020-2140-0
36
screening technologies, such as newer stool-based tests, CT colonography, or colon
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/liquid-biopsy-topicrefinement.pdf
July 29, 2021 - Circulating Tumor DNA
Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon … s41586-020-2140-0
36
screening technologies, such as newer stool-based tests, CT colonography, or colon
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/liquid-biopsy-topicrefinement.pdf
July 29, 2021 - Circulating Tumor DNA
Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon … s41586-020-2140-0
36
screening technologies, such as newer stool-based tests, CT colonography, or colon
-
pbrn.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/liquid-biopsy-topicrefinement.pdf
July 29, 2021 - Circulating Tumor DNA
Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon … s41586-020-2140-0
36
screening technologies, such as newer stool-based tests, CT colonography, or colon
-
pcmh.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/liquid-biopsy-topicrefinement.pdf
July 29, 2021 - Circulating Tumor DNA
Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon … s41586-020-2140-0
36
screening technologies, such as newer stool-based tests, CT colonography, or colon
-
healthcare411.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/liquid-biopsy-topicrefinement.pdf
July 29, 2021 - Circulating Tumor DNA
Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon … s41586-020-2140-0
36
screening technologies, such as newer stool-based tests, CT colonography, or colon
-
cahps.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/liquid-biopsy-topicrefinement.pdf
July 29, 2021 - Circulating Tumor DNA
Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon … s41586-020-2140-0
36
screening technologies, such as newer stool-based tests, CT colonography, or colon
-
preventiveservices.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/liquid-biopsy-topicrefinement.pdf
July 29, 2021 - Circulating Tumor DNA
Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon … s41586-020-2140-0
36
screening technologies, such as newer stool-based tests, CT colonography, or colon
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/liquid-biopsy-topicrefinement.pdf
July 29, 2021 - Circulating Tumor DNA
Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon … s41586-020-2140-0
36
screening technologies, such as newer stool-based tests, CT colonography, or colon
-
www.ahrq.gov/news/newsroom/ahrq-stats.html
January 01, 2025 - Colon Cancer Screenings Among women ages 50–64, 61.2 percent received colon cancer screening in 2015,
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2013%20(4).pdf
November 01, 2013 - falls significantly decreases about a year after starting vitamin D, and it takes
10 years after colon … serious bleeding problems, and colonoscopy to detect colorectal cancer can puncture a hole
in the colon
-
digital.ahrq.gov/sites/default/files/docs/publication/uc1hs015337-mingle-final-report-2008.pdf
January 01, 2008 - Preventive measures (breast cancer screen; colon cancer
screening; cervical cancer screening) were reviewed
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017163-baker-final-report-2011.pdf
January 01, 2011 - measures (e.g., aspirin being prescribed for primary prevention for
patients with diabetes; completion of colon
-
www.ahrq.gov/sites/default/files/2024-07/robins-report.pdf
January 01, 2024 - yourself whether you feel able to address all the
patient's concerns
So snoring, wife's complaining, colon
-
www.ahrq.gov/sites/default/files/2024-07/kukafka-report.pdf
January 01, 2024 - Colon cancer: Risk
perceptions and risk communication.
-
hcup-us.ahrq.gov/reports/statbriefs/sb214-Hysterectomy-Oophorectomy-Trends.jsp
November 01, 2016 - conditions
All other diagnoses including but not limited to cancer of breast (CCS category 24), cancer of colon
-
digital.ahrq.gov/sites/default/files/docs/citation/r01hs025429-aguilera-final-report-2022.pdf
January 01, 2022 - Colon E, Giachello A, McIver L, et al. Diabetes and depression in the Hispanic/Latino
community.